In this study we found that patients with typical symptoms that persisted at a high level despite PPI therapy (≥15 on GERD-HRQL), and objective evidence of GERD (by endoscopy or reflux testing) could expect a good response to TF. This evidence concerns the gene TF and gastroesophageal reflux disease.